NO951995D0 - Kombinasjon av atovaquon med proguantil for behandling av protozoinfeksjoner - Google Patents

Kombinasjon av atovaquon med proguantil for behandling av protozoinfeksjoner

Info

Publication number
NO951995D0
NO951995D0 NO951995A NO951995A NO951995D0 NO 951995 D0 NO951995 D0 NO 951995D0 NO 951995 A NO951995 A NO 951995A NO 951995 A NO951995 A NO 951995A NO 951995 D0 NO951995 D0 NO 951995D0
Authority
NO
Norway
Prior art keywords
proguantil
atovaquone
treatment
combination
protozoal infections
Prior art date
Application number
NO951995A
Other languages
English (en)
Other versions
NO951995L (no
NO313225B1 (no
Inventor
Winston Edward Gutteridge
David Brian Ashton Hutchinson
Victoria Susan Latter
Mary Pudney
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10725687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO951995(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO951995D0 publication Critical patent/NO951995D0/no
Publication of NO951995L publication Critical patent/NO951995L/no
Publication of NO313225B1 publication Critical patent/NO313225B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19951995A 1992-11-26 1995-05-19 Kombinasjon av atovaquon og proguanil for behandling av protozoinfeksjoner NO313225B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929224739A GB9224739D0 (en) 1992-11-26 1992-11-26 Medicaments
PCT/GB1993/002425 WO1994012164A1 (en) 1992-11-26 1993-11-25 Combination of atovaquone with proguanil for the treatment of protozoal infections

Publications (3)

Publication Number Publication Date
NO951995D0 true NO951995D0 (no) 1995-05-19
NO951995L NO951995L (no) 1995-07-03
NO313225B1 NO313225B1 (no) 2002-09-02

Family

ID=10725687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19951995A NO313225B1 (no) 1992-11-26 1995-05-19 Kombinasjon av atovaquon og proguanil for behandling av protozoinfeksjoner

Country Status (38)

Country Link
US (3) US5998449A (no)
EP (1) EP0670719B1 (no)
JP (1) JP3768231B2 (no)
KR (1) KR100294802B1 (no)
CN (1) CN1087935C (no)
AP (1) AP517A (no)
AT (1) ATE191340T1 (no)
AU (1) AU685408B2 (no)
BG (1) BG62595B1 (no)
CA (1) CA2150234E (no)
CY (1) CY2193B1 (no)
CZ (2) CZ289171B6 (no)
DE (1) DE69328307T2 (no)
DK (1) DK0670719T3 (no)
ES (1) ES2145114T3 (no)
GB (1) GB9224739D0 (no)
GR (1) GR3033745T3 (no)
HK (1) HK1004468A1 (no)
HU (1) HU225918B1 (no)
IL (1) IL107755A (no)
MX (1) MX9307402A (no)
MY (1) MY114241A (no)
NO (1) NO313225B1 (no)
NZ (1) NZ257901A (no)
OA (1) OA10352A (no)
PE (1) PE55694A1 (no)
PL (1) PL174323B1 (no)
PT (1) PT670719E (no)
RO (1) RO119280B1 (no)
RU (1) RU2108092C1 (no)
SA (1) SA93140434B1 (no)
SG (1) SG45387A1 (no)
SI (1) SI9300614A (no)
SK (1) SK281559B6 (no)
TW (1) TW253835B (no)
UA (1) UA45948C2 (no)
WO (1) WO1994012164A1 (no)
ZA (1) ZA938832B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9424013D0 (en) * 1994-11-29 1995-01-18 Wellcome Found Medicaments
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
GB9822681D0 (en) * 1998-10-16 1998-12-09 Vitabiotics Ltd Method of treatment
TR200102843T2 (tr) * 1999-04-09 2002-01-21 Glaxo Group Limited Sıtma tedavisi için kombine terkip.
US7104076B2 (en) * 2004-06-24 2006-09-12 Carrier Corporation Lubricant return schemes for use in refrigerant cycle
ITMI20070941A1 (it) * 2007-05-09 2008-11-10 Chimico Internazi0Nale S P A L Procedimento per la preparazione di naftochinoni trans2,3-disostituiti
EP2467358B1 (en) * 2009-08-20 2014-07-23 IPCA Laboratories Limited Novel complex for treatment and/or prophylaxis of parasitic infections
US20180055835A1 (en) 2016-08-25 2018-03-01 Immune Therapeutics Inc. Method for Treating And Preventing Protozoal Infections

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533648A (en) * 1949-03-05 1950-12-12 Joseph H Warburg Circular saw making
NL6411993A (no) * 1963-10-18 1965-04-20
US3347830A (en) * 1964-07-30 1967-10-17 Grace W R & Co Process of polymerizing formaldehyde
GB1141735A (en) * 1966-11-23 1969-01-29 Pfizer & Co C Pharmaceutical anti-tumor composition
NL6817526A (no) * 1968-01-24 1969-07-28
US3655699A (en) * 1970-03-02 1972-04-11 Pfizer Analogues of lapachol as antitumor agents
DE2601458A1 (de) * 1975-01-20 1976-07-22 Ciba Geigy Ag Loesliche, von phenylindandiaminen abgeleitete polyamide
EG14152A (en) * 1977-11-22 1983-12-31 Wellcome Found Antitheilerial naphtoquinone derivatives
US4485116A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
US4485117A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
JPS59196467A (ja) * 1983-04-23 1984-11-07 Nissan Motor Co Ltd 車輪速及びまたは車輪加減速度検出方法
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
EP0362996B1 (en) * 1988-08-16 1994-04-27 The Wellcome Foundation Limited Naphthoquinones for the treatment and prophylaxis of pneumocystis carinii infections
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
US5014737A (en) * 1989-11-13 1991-05-14 Allan Berman Quartz integrated trough/sump recirculating filtered high-purity chemical bath
GB9121316D0 (en) * 1991-10-09 1991-11-20 Wellcome Found Heterocyclic compounds
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
AU669300B2 (en) * 1993-05-05 1996-05-30 Palo Alto Medical Foundation Use of rifamycin derivatives for the manufacture of a medicament for the treatment of toxoplasmosis
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis
US5733932A (en) * 1995-01-06 1998-03-31 The Picower Institute For Medical Research Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
US5827543A (en) * 1995-12-07 1998-10-27 The Procter & Gamble Company Methods and compositions for the prevention and treatment of urogenital disorders
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
ZA983331B (en) * 1997-05-01 1998-10-27 Allegheny University Of The He Method for treating protozoal infections
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
TR200102843T2 (tr) * 1999-04-09 2002-01-21 Glaxo Group Limited Sıtma tedavisi için kombine terkip.

Also Published As

Publication number Publication date
NZ257901A (en) 1997-01-29
CA2150234C (en) 2001-01-16
EP0670719B1 (en) 2000-04-05
DE69328307T2 (de) 2000-10-26
US6291488B1 (en) 2001-09-18
SA93140434B1 (ar) 2004-09-01
KR100294802B1 (ko) 2001-09-17
CY2193B1 (en) 2002-11-08
GR3033745T3 (en) 2000-10-31
DE69328307D1 (de) 2000-05-11
CZ289692B6 (cs) 2002-03-13
SG45387A1 (en) 1998-01-16
CN1091632A (zh) 1994-09-07
CN1087935C (zh) 2002-07-24
AP9300592A0 (en) 1994-01-31
ES2145114T3 (es) 2000-07-01
IL107755A (en) 2000-10-31
RO119280B1 (ro) 2004-07-30
CZ289171B6 (cs) 2001-11-14
CA2150234A1 (en) 1994-06-09
DK0670719T3 (da) 2000-07-31
AU685408B2 (en) 1998-01-22
PT670719E (pt) 2000-09-29
PL309222A1 (en) 1995-10-02
TW253835B (no) 1995-08-11
WO1994012164A1 (en) 1994-06-09
OA10352A (en) 2001-10-22
MY114241A (en) 2002-09-30
NO951995L (no) 1995-07-03
HUT71346A (en) 1995-11-28
ZA938832B (en) 1995-05-25
MX9307402A (es) 1994-07-29
JP3768231B2 (ja) 2006-04-19
CA2150234E (en) 2005-03-22
AP517A (en) 1996-08-23
BG62595B1 (bg) 2000-03-31
HU225918B1 (en) 2007-12-28
UA45948C2 (uk) 2002-05-15
PE55694A1 (es) 1995-01-25
SI9300614A (en) 1994-06-30
NO313225B1 (no) 2002-09-02
JPH08503938A (ja) 1996-04-30
IL107755A0 (en) 1994-02-27
GB9224739D0 (en) 1993-01-13
US6166046A (en) 2000-12-26
EP0670719A1 (en) 1995-09-13
RU2108092C1 (ru) 1998-04-10
ATE191340T1 (de) 2000-04-15
CZ119295A3 (en) 1995-11-15
SK57095A3 (en) 1996-05-08
SK281559B6 (sk) 2001-05-10
US5998449A (en) 1999-12-07
BG99656A (bg) 1996-04-30
PL174323B1 (pl) 1998-07-31
HU9501537D0 (en) 1995-07-28
AU5532294A (en) 1994-06-22
HK1004468A1 (en) 1998-11-27

Similar Documents

Publication Publication Date Title
NO934304L (no) Fremgangsmaate for behandling av fluoralumosilikatglass
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
FI944885A (fi) Tölkin perusosa
FI930657A0 (fi) Foerfarande foer framstaellning av doseringsformer med foerlaengd aktivaemnesfrigivning
FI921260A (fi) Faestanordning foer loeslagbar anslutning av tvao profilstycken
FI930376A (fi) Tillslutningsanordning av gaengtyp med saekringsorgan
EP0559791A4 (en) Treatment of topical infections
NO940810D0 (no) Behandling av virusinfeksjoner
NO951995L (no) Kombinasjon av atovaquon med proguantil for behandling av protozoinfeksjoner
FI931322A0 (fi) Stabilisering av peroxidblekningsvaetskor med klordioxid
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO920983D0 (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
AU6130194A (en) 1,2-dithiole-3-thiones for the treatment of reverse transcriptase-dependent viral infections
FI951494A0 (fi) Jyvien käsittely laajentimella
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
ITRM930259A0 (it) Procedimento per la purificazione e stabilizzazione di perfluoropolieteri.
NO941594L (no) Behandling av protozoinfeksjon med bacitracin
FI920582A0 (fi) Anordningar foer upploesning av smaelta i en sodapanna.
ZA941471B (en) Treatment of viral infections
NO941063L (no) Behandling av faststoffmateriale
FIU920147U0 (fi) Anordning foer torkning av nyttovaexter med solenergi
HU9502697D0 (en) Drogs for the treatment of retrovirus infections
FIU930416U0 (fi) Transportoer foer lastning av broilrar
FI920883A0 (fi) Anordning foer vaessning av bett i en motorsaogskedja.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THE WELLCOME FOUNDATION LTD, GB

MK1K Patent expired